The Cigna Group financials
$275.26+1.26%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71.40B | $68.29B | $72.13B | $69.52B | $66.94B | $65.26B | $65.37B | $63.61B | $60.20B | $56.97B | $50.82B | $48.73B |
| Gross profit | $6.26B | $6.27B | $6.08B | $6.14B | $5.92B | $6.37B | $6.18B | $6.52B | $6.20B | $6.09B | $6.28B | $6.16B |
| Gross margin | 8.8% | 9.2% | 8.4% | 8.8% | 8.9% | 9.8% | 9.5% | 10.2% | 10.3% | 10.7% | 12.4% | 12.6% |
| Operating income | $2.40B | $2.16B | $2.01B | $2.35B | $2.07B | $1.73B | $1.90B | $2.49B | $2.09B | $1.97B | $1.77B | $1.92B |
| Net income | $1.66B | $1.65B | $1.23B | $1.87B | $1.53B | $1.32B | $1.42B | $739.0M | $1.55B | -$277.0M | $1.03B | $1.41B |
| Net margin | 2.3% | 2.4% | 1.7% | 2.7% | 2.3% | 2.0% | 2.2% | 1.2% | 2.6% | −0.5% | 2.0% | 2.9% |
| Diluted EPS | $6.29 | $6.26 | $4.65 | $6.98 | $5.71 | $4.85 | $5.07 | $2.63 | $5.45 | $-0.97 | $3.49 | $4.74 |
| EBITDA | $3.06B | $2.81B | $2.73B | $3.04B | $2.75B | $2.41B | $2.54B | $3.14B | $2.83B | $2.71B | $1.77B | $2.69B |
| Operating cash flow | -$421.0M | $1.13B | $6.15B | $3.42B | -$1.89B | $1.92B | $5.21B | $46.0M | $265.0M | $4.84B | $1.47B | $2.83B |
| Free cash flow | -$718.0M | $864.0M | $5.83B | $3.14B | -$2.17B | $1.59B | $4.88B | -$353.0M | -$105.0M | $4.54B | $1.10B | $2.42B |
| Diluted shares | 264.0M | 264.0M | 265.6M | 267.5M | 268.2M | 273.0M | 281.0M | 281.4M | 284.1M | 286.5M | 294.5M | 297.1M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.30B | $7.04B | $7.68B | $6.03B | $4.33B | $8.33B |
| Short-term investments | $959.0M | $812.0M | $1.06B | $883.0M | $813.0M | $727.0M |
| Total debt | $31.88B | $30.90B | $31.46B | $34.04B | $30.77B | $30.45B |
| Total assets | $157.08B | $153.27B | $157.92B | $157.92B | $151.65B | $150.66B |
| Total liabilities | $114.17B | $110.82B | $116.05B | $115.91B | $111.22B | $110.24B |
| Shareholders' equity | $42.91B | $42.44B | $41.87B | $42.01B | $40.43B | $40.41B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology